{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T19:05:19Z","timestamp":1794769519052,"version":"4.9.1"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2320-B-038 -018 -MY3"],"award-info":[{"award-number":["NSTC 112-2320-B-038 -018 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002811","name":"Cathay General Hospital","doi-asserted-by":"publisher","award":["CGH-MR-A11315"],"award-info":[{"award-number":["CGH-MR-A11315"]}],"id":[{"id":"10.13039\/501100002811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002811","name":"Cathay General Hospital","doi-asserted-by":"publisher","award":["CGH-MR-A11314"],"award-info":[{"award-number":["CGH-MR-A11314"]}],"id":[{"id":"10.13039\/501100002811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chitinase-3-like-1 (CHI3L1) is an evolutionarily conserved protein involved in key biological processes, including tissue remodeling, angiogenesis, and neuroinflammation. It has emerged as a significant player in various neurodegenerative diseases and brain disorders. Elevated CHI3L1 levels have been observed in neurological conditions such as traumatic brain injury (TBI), Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Amyotrophic lateral sclerosis (ALS), Creutzfeldt-Jakob disease (CJD), multiple sclerosis (MS), Neuromyelitis optica (NMO), HIV-associated dementia (HAD), Cerebral ischemic stroke (CIS), and brain tumors. This review explores the role of CHI3L1 in the pathogenesis of these disorders, with a focus on its contributions to neuroinflammation, immune cell infiltration, and neuronal degeneration. As a key regulator of neuroinflammation, CHI3L1 modulates microglia and astrocyte activity, driving the release of proinflammatory cytokines that exacerbate disease progression. In addition to its role in disease pathology, CHI3L1 has emerged as a promising biomarker for the diagnosis and monitoring of brain disorders. Elevated cerebrospinal fluid (CSF) levels of CHI3L1 have been linked to disease severity and cognitive decline, particularly in AD and MS, highlighting its potential for clinical diagnostics. Furthermore, therapeutic strategies targeting CHI3L1, such as small-molecule inhibitors and neutralizing antibodies, have shown promise in preclinical studies, demonstrating reduced neuroinflammation, amyloid plaque accumulation, and improved neuronal survival. Despite its therapeutic potential, challenges remain in developing selective and safe CHI3L1-targeted therapies, particularly in ensuring effective delivery across the blood\u2013brain barrier and mitigating off-target effects. This review addresses the complexities of targeting CHI3L1, highlights its potential in precision medicine, and outlines future research directions aimed at unlocking its full therapeutic potential in treating neurodegenerative diseases and brain pathologies.<\/jats:p>","DOI":"10.1186\/s13024-025-00801-8","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T01:16:19Z","timestamp":1737162979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications"],"prefix":"10.1186","volume":"20","author":[{"given":"Pharaoh Fellow","family":"Mwale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ta","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Lin","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Shiun","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Taliyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8354-7874","authenticated-orcid":false,"given":"Chih-Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"1","key":"801_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","volume":"5","author":"T Zhao","year":"2020","unstructured":"Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5(1):201.","journal-title":"Signal Transduct Target Ther"},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00415-011-6087-9","volume":"258","author":"J Choi","year":"2011","unstructured":"Choi J, Lee H-W, Suk K. Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer\u2019s disease. J Neurol. 2011;258:2181\u20135.","journal-title":"J Neurol"},{"issue":"2","key":"801_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clim.2015.10.003","volume":"161","author":"CA Wiley","year":"2015","unstructured":"Wiley CA, Bissel SJ, Murdoch GH. Role of CHI3L1 in neuroinflammation. Clin Immunol (Orlando, Fla). 2015;161(2):354.","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"12","key":"801_CR4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1369\/jhc.7A7245.2007","volume":"55","author":"JS Johansen","year":"2007","unstructured":"Johansen JS, H\u00f8yer PE, Larsen LA, Price PA, M\u00f8llg\u00e5rd K. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem. 2007;55(12):1213\u201328.","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"801_CR5","first-page":"172","volume":"53","author":"JS Johansen","year":"2006","unstructured":"Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull. 2006;53(2):172\u2013209.","journal-title":"Dan Med Bull"},{"key":"801_CR6","doi-asserted-by":"publisher","first-page":"114520","DOI":"10.1016\/j.biopha.2023.114520","volume":"161","author":"A Rusak","year":"2023","unstructured":"Rusak A, Buzalewicz I, Mrozowska M, Wiatrak B, Haczkiewicz-Le\u015bniak K, Olbromski M, et al. Multimodal study of CHI3L1 inhibition and its effect on angiogenesis, migration, immune response and refractive index of cellular structures in glioblastoma. Biomed Pharmacother. 2023;161:114520.","journal-title":"Biomed Pharmacother"},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jns.2017.09.006","volume":"381","author":"MR Pranzatelli","year":"2017","unstructured":"Pranzatelli MR, Tate ED, McGee NR. Microglial\/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: a case-control study and reference ranges. J Neurol Sci. 2017;381:285\u201390.","journal-title":"J Neurol Sci"},{"issue":"5","key":"801_CR8","doi-asserted-by":"publisher","first-page":"e0233519","DOI":"10.1371\/journal.pone.0233519","volume":"15","author":"P Ku\u0161nierov\u00e1","year":"2020","unstructured":"Ku\u0161nierov\u00e1 P, Zeman D, Hrad\u00edlek P, Zapletalov\u00e1 O, Stejskal D. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases. PLoS ONE. 2020;15(5):e0233519.","journal-title":"PLoS ONE"},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-016-0492-4","volume":"11","author":"G Steponaitis","year":"2016","unstructured":"Steponaitis G, Skiriut\u0117 D, Kazlauskas A, Golubickait\u0117 I, Stakaitis R, Tama\u0161auskas A, et al. High CHI3L1 expression is associated with glioma patient survival. Diagn Pathol. 2016;11:1\u20138.","journal-title":"Diagn Pathol"},{"key":"801_CR10","unstructured":"Lao S. Chitinase-3-like-Protein-1 and its role in vascular smooth muscle cell survival in advanced atherosclerosis. Doctoral dissertation, Technische Universit\u00e4t M\u00fcnchen; 2020."},{"issue":"7","key":"801_CR11","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.3390\/ijms24076301","volume":"24","author":"C Russo","year":"2023","unstructured":"Russo C, Valle MS, Casabona A, Malaguarnera L. Chitinase signature in the plasticity of neurodegenerative diseases. Int J Mol Sci. 2023;24(7):6301.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"801_CR12","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.3390\/cells12212546","volume":"12","author":"HW Chang","year":"2023","unstructured":"Chang HW, Hsu MJ, Chien LN, Chi NF, Yu MC, Chen HC, et al. Role of the autism risk gene Shank3 in the development of atherosclerosis: insights from big data and mechanistic analyses. Cells. 2023;12(21):2546.","journal-title":"Cells"},{"key":"801_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s10753-012-9569-8","volume":"36","author":"M Di Rosa","year":"2013","unstructured":"Di Rosa M, Malaguarnera G, De Gregorio C, Drago F, Malaguarnera L. Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages. Inflammation. 2013;36:482\u201392.","journal-title":"Inflammation"},{"issue":"4","key":"801_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","volume":"22","author":"D Bonneh-Barkay","year":"2012","unstructured":"Bonneh-Barkay D, Bissel SJ, Kofler J, Starkey A, Wang G, Wiley CA. Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation. Brain Pathol. 2012;22(4):530\u201346.","journal-title":"Brain Pathol"},{"issue":"2","key":"801_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.imbio.2015.09.023","volume":"221","author":"M Di Rosa","year":"2016","unstructured":"Di Rosa M, Tibullo D, Saccone S, Distefano G, Basile MS, Di Raimondo F, et al. CHI3L1 nuclear localization in monocyte derived dendritic cells. Immunobiology. 2016;221(2):347\u201356.","journal-title":"Immunobiology"},{"issue":"6","key":"801_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/10408360802334743","volume":"45","author":"FD Coffman","year":"2008","unstructured":"Coffman FD. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci. 2008;45(6):531\u201362.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"801_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-7-34","volume":"7","author":"D Bonneh-Barkay","year":"2010","unstructured":"Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation. 2010;7:1\u20138.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"801_CR18","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1038\/s41598-020-64093-2","volume":"10","author":"C Matute-Blanch","year":"2020","unstructured":"Matute-Blanch C, Calvo-Barreiro L, Carballo-Carbajal I, Gonzalo R, Sanchez A, Vila M, et al. Chitinase 3-like 1 is neurotoxic in primary cultured neurons. Sci Rep. 2020;10(1):7118.","journal-title":"Sci Rep"},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"622360","DOI":"10.3389\/fnagi.2020.622360","volume":"12","author":"P Molina-Mart\u00ednez","year":"2021","unstructured":"Molina-Mart\u00ednez P, Corpas R, Garc\u00eda-Lara E, Cos\u00edn-Tom\u00e1s M, Crist\u00f2fol R, Kaliman P, et al. Microglial hyperreactivity evolved to immunosuppression in the hippocampus of a mouse model of accelerated aging and Alzheimer\u2019s Disease traits. Front Aging Neurosci. 2021;12:622360.","journal-title":"Front Aging Neurosci"},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"1056397","DOI":"10.3389\/fimmu.2022.1056397","volume":"13","author":"B Ma","year":"2022","unstructured":"Ma B, Kamle S, Akosman B, Khan H, Lee C-M, Lee CG, et al. CHI3L1 enhances melanoma lung metastasis via regulation of T cell co-stimulators and CTLA-4\/B7 axis. Front Immunol. 2022;13:1056397.","journal-title":"Front Immunol"},{"issue":"9","key":"801_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/diagnostics11091655","volume":"11","author":"CM Pedrero-Prieto","year":"2021","unstructured":"Pedrero-Prieto CM, Fronti\u00f1\u00e1n-Rubio J, Alca\u00edn FJ, Dur\u00e1n-Prado M, Peinado JR, Rabanal-Ruiz Y. Biological significance of the protein changes occurring in the Cerebrospinal Fluid of Alzheimer\u2019s Disease Patients: getting clues from Proteomic Studies. Diagnostics. 2021;11(9):1655.","journal-title":"Diagnostics"},{"key":"801_CR22","doi-asserted-by":"crossref","unstructured":"Shi G, Li M, Yan E, Zhou J, Wang M, Gong P, et al. YKL-40: a potential prognostic predictor of one-year clinical outcomes in patients with acute ischemic stroke. 2022.","DOI":"10.21203\/rs.3.rs-2080278\/v1"},{"key":"801_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuroscience.2022.10.018","volume":"506","author":"D Yilmazer-Hanke","year":"2022","unstructured":"Yilmazer-Hanke D, Alami NO, Fang L, Klotz S, Kovacs GG, Pankratz H, et al. Differential glial Chitotriosidase 1 and Chitinase 3-like protein 1 expression in the human primary visual cortex and cerebellum after global hypoxia-ischemia. Neuroscience. 2022;506:91\u2013113.","journal-title":"Neuroscience"},{"issue":"4","key":"801_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/brain\/awv017","volume":"138","author":"E Canto","year":"2015","unstructured":"Canto E, Tintore M, Villar LM, Costa C, Nurtdinov R, Alvarez-Cermeno JC, et al. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. Brain. 2015;138(4):918\u201331.","journal-title":"Brain"},{"issue":"6","key":"801_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1189\/jlb.3VMR0415-142R","volume":"98","author":"S Libreros","year":"2015","unstructured":"Libreros S, Iragavarapu-Charyulu V. YKL-40\/CHI3L1 drives inflammation on the road of tumor progression. J Leucocyte Biol. 2015;98(6):931\u20136.","journal-title":"J Leucocyte Biol"},{"issue":"8","key":"801_CR26","doi-asserted-by":"publisher","first-page":"e0135458","DOI":"10.1371\/journal.pone.0135458","volume":"10","author":"M Wennstr\u00f6m","year":"2015","unstructured":"Wennstr\u00f6m M, Surova Y, Hall S, Nilsson C, Minthon L, Hansson O, et al. The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies. PLoS ONE. 2015;10(8):e0135458.","journal-title":"PLoS ONE"},{"issue":"3","key":"801_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00702-022-02470-z","volume":"129","author":"S Haji","year":"2022","unstructured":"Haji S, Sako W, Murakami N, Osaki Y, Izumi Y. Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis. J Neural Transm. 2022;129(3):301\u20139.","journal-title":"J Neural Transm"},{"key":"801_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fneur.2020.00377","volume":"11","author":"N Gaur","year":"2020","unstructured":"Gaur N, Perner C, Witte OW, Grosskreutz J. The chitinases as biomarkers for amyotrophic lateral sclerosis: signals from the CNS and beyond. Front Neurol. 2020;11:377.","journal-title":"Front Neurol"},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0226-4","volume":"12","author":"F Llorens","year":"2017","unstructured":"Llorens F, Th\u00fcne K, Tahir W, Kanata E, Diaz-Lucena D, Xanthopoulos K, et al. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener. 2017;12:1\u201321.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"801_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann P, Appleby B, Brandel J-P, Caughey B, Collins S, Geschwind MD, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20(3):235\u201346.","journal-title":"Lancet Neurol"},{"issue":"39","key":"801_CR31","doi-asserted-by":"publisher","first-page":"eadg8148","DOI":"10.1126\/sciadv.adg8148","volume":"9","author":"W Jiang","year":"2023","unstructured":"Jiang W, Zhu F, Xu H, Xu L, Li H, Yang X, et al. CHI3L1 signaling impairs hippocampal neurogenesis and cognitive function in autoimmune-mediated neuroinflammation. Sci Adv. 2023;9(39):eadg8148.","journal-title":"Sci Adv"},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11908-015-0485-6","volume":"17","author":"MR Etherton","year":"2015","unstructured":"Etherton MR, Lyons JL, Ard KL. HIV-associated neurocognitive disorders and antiretroviral therapy: current concepts and controversies. Curr Infect Dis Rep. 2015;17:1\u20136.","journal-title":"Curr Infect Dis Rep"},{"issue":"6","key":"801_CR33","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.jcf.2020.11.011","volume":"20","author":"A Coriati","year":"2021","unstructured":"Coriati A, Bouvet GF, Mass\u00e9 C, Ducruet T, Berthiaume Y. Ykl-40 as a clinical biomarker in adult patients with cf: implications of a chi3l1 single nucleotide polymorphism in disease severity. J Cyst Fibros. 2021;20(6):e93\u20139.","journal-title":"J Cyst Fibros"},{"key":"801_CR34","doi-asserted-by":"publisher","first-page":"107394","DOI":"10.1016\/j.pharmthera.2019.107394","volume":"203","author":"IJ Yeo","year":"2019","unstructured":"Yeo IJ, Lee C-K, Han S-B, Yun J, Hong JT. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacol Ther. 2019;203:107394.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"801_CR35","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","volume":"91","author":"S Janelidze","year":"2018","unstructured":"Janelidze S, Mattsson N, Stomrud E, Lindberg O, Palmqvist S, Zetterberg H, et al. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease. Neurology. 2018;91(9):e867\u201377.","journal-title":"Neurology"},{"issue":"4","key":"801_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/14789450.2017.1304217","volume":"14","author":"F Baldacci","year":"2017","unstructured":"Baldacci F, Lista S, Cavedo E, Bonuccelli U, Hampel H. Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer\u2019s disease and other neurodegenerative diseases. Expert Rev Proteomics. 2017;14(4):285\u201399.","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"801_CR37","first-page":"e921","volume":"8","author":"R Pinteac","year":"2020","unstructured":"Pinteac R, Montalban X, Comabella M. Chitinases and chitinase-like proteins as biomarkers in neurologic disorders. Neurology. 2020;8(1):e921.","journal-title":"Neurology"},{"issue":"7","key":"801_CR38","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/14789450.2019.1633919","volume":"16","author":"C Thygesen","year":"2019","unstructured":"Thygesen C, Larsen MR, Finsen B. Proteomic signatures of neuroinflammation in Alzheimer\u2019s disease, multiple sclerosis and ischemic stroke. Expert Rev Proteomics. 2019;16(7):601\u201311.","journal-title":"Expert Rev Proteomics"},{"issue":"16","key":"801_CR39","doi-asserted-by":"publisher","first-page":"6989","DOI":"10.7150\/thno.75069","volume":"12","author":"T Zhao","year":"2022","unstructured":"Zhao T, Zeng J, Xu Y, Su Z, Chong Y, Ling T, et al. Chitinase-3 like-protein-1 promotes glioma progression via the NF-\u03baB signaling pathway and tumor microenvironment reprogramming. Theranostics. 2022;12(16):6989.","journal-title":"Theranostics"},{"issue":"1","key":"801_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7150\/thno.65522","volume":"12","author":"P-S Yang","year":"2022","unstructured":"Yang P-S, Yu M-H, Hou Y-C, Chang C-P, Lin S-C, Kuo I-Y, et al. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy. Theranostics. 2022;12(1):340.","journal-title":"Theranostics"},{"key":"801_CR41","doi-asserted-by":"publisher","first-page":"7403747","DOI":"10.1155\/2017\/7403747","volume":"2017","author":"SA Vald\u00e9s-Rives","year":"2017","unstructured":"Vald\u00e9s-Rives SA, Casique-Aguirre D, Germ\u00e1n-Castel\u00e1n L, Velasco-Vel\u00e1zquez MA, Gonz\u00e1lez-Arenas A. Apoptotic signaling pathways in glioblastoma and therapeutic implications. BioMed Res Int. 2017;2017:7403747.","journal-title":"BioMed Res Int"},{"issue":"11","key":"801_CR42","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nn.2951","volume":"14","author":"M Tymianski","year":"2011","unstructured":"Tymianski M. Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat Neurosci. 2011;14(11):1369\u201373.","journal-title":"Nat Neurosci"},{"issue":"4","key":"801_CR43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bpa.2010.10.001","volume":"24","author":"A Kunz","year":"2010","unstructured":"Kunz A, Dirnagl U, Mergenthaler P. Acute pathophysiological processes after ischaemic and traumatic brain injury. Best Pract Res Clin Anaesthesiol. 2010;24(4):495\u2013509.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"801_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fped.2014.00144","volume":"2","author":"US Bhalala","year":"2015","unstructured":"Bhalala US, Koehler RC, Kannan S. Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain. Front Pediatr. 2015;2:144.","journal-title":"Front Pediatr"},{"issue":"1","key":"801_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2014.10.025","volume":"454","author":"L Xu","year":"2014","unstructured":"Xu L, Li Y, Fu Q, Ma S. Perillaldehyde attenuates cerebral ischemia\u2013reperfusion injury-triggered overexpression of inflammatory cytokines via modulating Akt\/JNK pathway in the rat brain cortex. Biochem Biophys Res Commun. 2014;454(1):65\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"801_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1269-3","volume":"15","author":"JY Choi","year":"2018","unstructured":"Choi JY, Yeo IJ, Kim KC, Choi WR, Jung J-K, Han S-B, et al. K284\u20136111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-\u03baB-mediated CHI3L1 expression. J Neuroinflammation. 2018;15:1\u201313.","journal-title":"J Neuroinflammation"},{"key":"801_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-02022-w","volume":"17","author":"HJ Ham","year":"2020","unstructured":"Ham HJ, Lee YS, Yun J, Son DJ, Lee HP, Han S-B, et al. K284\u20136111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of Chitinase-3-like 1 regulating ERK-dependent PTX3 pathway. J Neuroinflammation. 2020;17:1\u201316.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"801_CR48","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1534\/genetics.107.075846","volume":"177","author":"AP Bussink","year":"2007","unstructured":"Bussink AP, Speijer D, Aerts JM, Boot RG. Evolution of mammalian chitinase (-like) members of family 18 glycosyl hydrolases. Genetics. 2007;177(2):959\u201370.","journal-title":"Genetics"},{"key":"801_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-016-0742-9","volume":"16","author":"Y Deming","year":"2016","unstructured":"Deming Y, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez MV, et al. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40. BMC Neurol. 2016;16:1\u20138.","journal-title":"BMC Neurol"},{"issue":"1","key":"801_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/alz.12612","volume":"19","author":"K Connolly","year":"2023","unstructured":"Connolly K, Lehoux M, O\u2019Rourke R, Assetta B, Erdemir GA, Elias JA, et al. Potential role of chitinase-3-like protein 1 (CHI3L1\/YKL-40) in neurodegeneration and Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(1):9\u201324.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"801_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/glycob\/cwr092","volume":"22","author":"Q-S Huang","year":"2012","unstructured":"Huang Q-S, Xie X-L, Liang G, Gong F, Wang Y, Wei X-Q, et al. The GH18 family of chitinases: their domain architectures, functions and evolutions. Glycobiology. 2012;22(1):23\u201334.","journal-title":"Glycobiology"},{"issue":"7","key":"801_CR52","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3390\/app11073212","volume":"11","author":"N Miguez","year":"2021","unstructured":"Miguez N, Kidibule P, Santos-Moriano P, Ballesteros AO, Fernandez-Lobato M, Plou FJ. Enzymatic synthesis and characterization of different families of chitooligosaccharides and their bioactive properties. Appl Sci. 2021;11(7):3212.","journal-title":"Appl Sci"},{"key":"801_CR53","doi-asserted-by":"publisher","first-page":"107553","DOI":"10.1016\/j.biotechadv.2020.107553","volume":"43","author":"W Chen","year":"2020","unstructured":"Chen W, Jiang X, Yang Q. Glycoside hydrolase family 18 chitinases: the known and the unknown. Biotechnol Adv. 2020;43:107553.","journal-title":"Biotechnol Adv"},{"issue":"3\u20134","key":"801_CR54","first-page":"208","volume":"16","author":"M Karlsson","year":"2009","unstructured":"Karlsson M, Stenlid J. Evolution of family 18 glycoside hydrolases: diversity, domain structures and phylogenetic relationships. J Mol Microbiol Biotechnol. 2009;16(3\u20134):208\u201323.","journal-title":"J Mol Microbiol Biotechnol"},{"key":"801_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2148-7-96","volume":"7","author":"JD Funkhouser","year":"2007","unstructured":"Funkhouser JD, Aronson NN. Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol Biol. 2007;7:1\u201316.","journal-title":"BMC Evol Biol"},{"key":"801_CR56","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00239-013-9553-4","volume":"76","author":"M Hussain","year":"2013","unstructured":"Hussain M, Wilson JB. New paralogues and revised time line in the expansion of the vertebrate GH18 family. J Mol Evol. 2013;76:240\u201360.","journal-title":"J Mol Evol"},{"issue":"1","key":"801_CR57","doi-asserted-by":"publisher","first-page":"12752","DOI":"10.1038\/ncomms12752","volume":"7","author":"C-M Lee","year":"2016","unstructured":"Lee C-M, He CH, Nour AM, Zhou Y, Ma B, Park JW, et al. IL-13R\u03b12 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses. Nat Commun. 2016;7(1):12752.","journal-title":"Nat Commun"},{"issue":"6","key":"801_CR58","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.4049\/jimmunol.1701442","volume":"200","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, He CH, Yang DS, Nguyen T, Cao Y, Kamle S, et al. Galectin-3 interacts with the CHI3L1 axis and contributes to Hermansky-Pudlak syndrome lung disease. J Immunol. 2018;200(6):2140\u201353.","journal-title":"J Immunol"},{"key":"801_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0876-2","volume":"37","author":"B Geng","year":"2018","unstructured":"Geng B, Pan J, Zhao T, Ji J, Zhang C, Che Y, et al. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through \u03b2-catenin\/Erk\/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37:1\u201320.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"801_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2015.07.148","volume":"465","author":"J Wang","year":"2015","unstructured":"Wang J, Su H-K, Zhao H-F, Chen Z-P, To SST. Progress in the application of molecular biomarkers in gliomas. Biochem Biophys Res Commun. 2015;465(1):1\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"801_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/neup.12158","volume":"35","author":"CA Wiley","year":"2015","unstructured":"Wiley CA, Bonneh-Barkay D, Dixon CE, Lesniak A, Wang G, Bissel SJ, et al. Role for mammalian chitinase 3-like protein 1 in traumatic brain injury. Neuropathology. 2015;35(2):95\u2013106.","journal-title":"Neuropathology"},{"issue":"7","key":"801_CR62","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.cellsig.2013.03.016","volume":"25","author":"M Prakash","year":"2013","unstructured":"Prakash M, Bodas M, Prakash D, Nawani N, Khetmalas M, Mandal A, et al. Diverse pathological implications of YKL-40: answers may lie in \u2018outside-in\u2019signaling. Cell Signal. 2013;25(7):1567\u201373.","journal-title":"Cell Signal"},{"issue":"2","key":"801_CR63","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/jnc.15350","volume":"158","author":"D Schmid","year":"2021","unstructured":"Schmid D, Warnken U, Latzer P, Hoffmann DC, Roth J, Kutschmann S, et al. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies. J Neurochem. 2021;158(2):522\u201338.","journal-title":"J Neurochem"},{"issue":"6","key":"801_CR64","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/ijc.25466","volume":"128","author":"BM Ku","year":"2011","unstructured":"Ku BM, Lee YK, Ryu J, Jeong JY, Choi J, Eun KM, et al. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. Int J Cancer. 2011;128(6):1316\u201326.","journal-title":"Int J Cancer"},{"issue":"5","key":"801_CR65","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","volume":"91","author":"BL Brett","year":"2022","unstructured":"Brett BL, Gardner RC, Godbout J, Dams-O\u2019Connor K, Keene CD. Traumatic brain injury and risk of neurodegenerative disorder. Biol Psychiatry. 2022;91(5):498\u2013507.","journal-title":"Biol Psychiatry"},{"issue":"22","key":"801_CR66","doi-asserted-by":"publisher","first-page":"16297","DOI":"10.3390\/ijms242216297","volume":"24","author":"M Gevezova","year":"2023","unstructured":"Gevezova M, Kazakova M, Trenova A, Sarafian V. YKL-40 and the cellular metabolic profile in Parkinson\u2019s disease. Int J Mol Sci. 2023;24(22):16297.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"801_CR67","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s10072-024-07301-5","volume":"45","author":"A Xu","year":"2024","unstructured":"Xu A, Luo Y, Tang Y, Yang F, Gao X, Qiao G, et al. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol Sci. 2024;45(6):2489\u2013503.","journal-title":"Neurol Sci"},{"issue":"4","key":"801_CR68","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1212\/NXI.0000000000001164","volume":"9","author":"S Floro","year":"2022","unstructured":"Floro S, Carandini T, Pietroboni AM, De Riz MA, Scarpini E, Galimberti D. Role of Chitinase 3\u2013like 1 as a biomarker in multiple sclerosis: a systematic review and meta-analysis. Neurol Neuroimmunol Neuroinflamm. 2022;9(4):e1164.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"801_CR69","doi-asserted-by":"publisher","first-page":"e972","DOI":"10.1212\/NXI.0000000000000972","volume":"8","author":"L Cubas-N\u00fa\u00f1ez","year":"2021","unstructured":"Cubas-N\u00fa\u00f1ez L, Gil-Perot\u00edn S, Castillo-Villalba J, L\u00f3pez V, Sol\u00eds Tarazona L, Gasqu\u00e9-Rubio R, et al. Potential role of CHI3L1+ astrocytes in progression in MS. Neurol Neuroimmunol Neuroinflamm. 2021;8(3):e972.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"801_CR70","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1570162033485122","volume":"1","author":"PR Gorry","year":"2003","unstructured":"Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A, et al. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res. 2003;1(4):463\u201373.","journal-title":"Curr HIV Res"},{"key":"801_CR71","doi-asserted-by":"publisher","first-page":"109158","DOI":"10.1016\/j.clim.2022.109158","volume":"245","author":"F Li","year":"2022","unstructured":"Li F, Qi B, Yang L, Wang B, Gao L, Zhao M, et al. CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment. Clin Immunol. 2022;245:109158.","journal-title":"Clin Immunol"},{"issue":"1","key":"801_CR72","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-022-02467-1","volume":"19","author":"J Li","year":"2022","unstructured":"Li J, Lin J, Pan Y, Wang M, Meng X, Li H, et al. Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study. J Neuroinflammation. 2022;19(1):131.","journal-title":"J Neuroinflammation"},{"key":"801_CR73","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1016\/j.wneu.2019.09.143","volume":"134","author":"CS Carabias","year":"2020","unstructured":"Carabias CS, Gomez PA, Panero I, Eiriz C, Casta\u00f1o-Le\u00f3n AM, Egea J, et al. Chitinase-3-like protein 1, serum amyloid A1, C-reactive protein, and procalcitonin are promising biomarkers for intracranial severity assessment of traumatic brain injury: relationship with glasgow coma scale and computed tomography volumetry. World Neurosurg. 2020;134:e120\u201343.","journal-title":"World Neurosurg"},{"key":"801_CR74","doi-asserted-by":"crossref","unstructured":"Carabias C, Lagares A. Chitinase-3-like protein 1: features and applications as a biomarker in traumatic brain injury. In: Diagnosis and treatment of traumatic brain injury. Cambridge: Academic Press; 2022. p. 251-75.","DOI":"10.1016\/B978-0-12-823347-4.00009-9"},{"issue":"1","key":"801_CR75","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/medicina58010060","volume":"58","author":"I Mavroudis","year":"2021","unstructured":"Mavroudis I, Chowdhury R, Petridis F, Karantali E, Chatzikonstantinou S, Balmus IM, et al. YKL-40 as a potential biomarker for the differential diagnosis of Alzheimer\u2019s disease. Medicina. 2021;58(1):60.","journal-title":"Medicina"},{"issue":"2","key":"801_CR76","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2217\/nmt-2022-0010","volume":"13","author":"MM Anwar","year":"2023","unstructured":"Anwar MM, Fathi MH. Early approaches of YKL-40 as a biomarker and therapeutic target for Parkinson\u2019s disease. Neurodegener Dis Manag. 2023;13(2):85\u201399.","journal-title":"Neurodegener Dis Manag"},{"issue":"13","key":"801_CR77","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/mds.25589","volume":"28","author":"B Olsson","year":"2013","unstructured":"Olsson B, Constantinescu R, Holmberg B, Andreasen N, Blennow K, Zetterberg H. The glial marker YKL-40 is decreased in synucleinopathies. Mov Disord. 2013;28(13):1882\u20135.","journal-title":"Mov Disord"},{"issue":"6","key":"801_CR78","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3390\/jcm12062367","volume":"12","author":"A Bombaci","year":"2023","unstructured":"Bombaci A, Manera U, De Marco G, Casale F, Salamone P, Fuda G, et al. Plasma CHI3L1 in amyotrophic lateral sclerosis: a potential differential diagnostic biomarker. J Clin Med. 2023;12(6):2367.","journal-title":"J Clin Med"},{"key":"801_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1531-3","volume":"16","author":"A Villar-Piqu\u00e9","year":"2019","unstructured":"Villar-Piqu\u00e9 A, Schmitz M, Hermann P, Goebel S, Bunck T, Varges D, et al. Plasma YKL-40 in the spectrum of neurodegenerative dementia. J Neuroinflammation. 2019;16:1\u20135.","journal-title":"J Neuroinflammation"},{"key":"801_CR80","doi-asserted-by":"publisher","first-page":"102395","DOI":"10.1016\/j.msard.2020.102395","volume":"45","author":"Y Qi","year":"2020","unstructured":"Qi Y, Chou L-S, Zhang L-J, Liu M-Q, Yi M, Zhang Q-X, et al. Increased cerebrospinal fluid YKL-40 levels are associated with disease severity of neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2020;45:102395.","journal-title":"Mult Scler Relat Disord"},{"key":"801_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1404-9","volume":"16","author":"L Hermansson","year":"2019","unstructured":"Hermansson L, Yilmaz A, Axelsson M, Blennow K, Fuchs D, Hagberg L, et al. Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection. J Neuroinflammation. 2019;16:1\u20139.","journal-title":"J Neuroinflammation"},{"issue":"10145","key":"801_CR82","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet. 2018;392(10145):432\u201346.","journal-title":"Lancet"},{"issue":"8","key":"801_CR83","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/neuonc\/noab076","volume":"23","author":"HA Wanis","year":"2021","unstructured":"Wanis HA, M\u00f8ller H, Ashkan K, Davies EA. The incidence of major subtypes of primary brain tumors in adults in England 1995\u20132017. Neuro Oncol. 2021;23(8):1371\u201382.","journal-title":"Neuro Oncol"},{"issue":"11","key":"801_CR84","doi-asserted-by":"publisher","first-page":"e003224","DOI":"10.1136\/jitc-2021-003224","volume":"9","author":"A Darwich","year":"2021","unstructured":"Darwich A, Silvestri A, Benmebarek M-R, Mouri\u00e8s J, Cadilha B, Melacarne A, et al. Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1. J Immunother Cancer. 2021;9(11):e003224.","journal-title":"J Immunother Cancer"},{"key":"801_CR85","doi-asserted-by":"publisher","first-page":"104119","DOI":"10.1016\/j.cellimm.2020.104119","volume":"353","author":"L-Q Fu","year":"2020","unstructured":"Fu L-Q, Du W-L, Cai M-H, Yao J-Y, Zhao Y-Y, Mou X-Z. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol. 2020;353:104119.","journal-title":"Cell Immunol"},{"key":"801_CR86","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fphys.2013.00122","volume":"4","author":"R Shao","year":"2013","unstructured":"Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol. 2013;4:122.","journal-title":"Front Physiol"},{"issue":"6","key":"801_CR87","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.18632\/oncotarget.14155","volume":"8","author":"V Salvatore","year":"2017","unstructured":"Salvatore V, Teti G, Focaroli S, Mazzotti MC, Mazzotti A, Falconi M. The tumor microenvironment promotes cancer progression and cell migration. Oncotarget. 2017;8(6):9608.","journal-title":"Oncotarget"},{"issue":"1","key":"801_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2015.03.015","volume":"362","author":"I Paw","year":"2015","unstructured":"Paw I, Carpenter RC, Watabe K, Debinski W, Lo H-W. Mechanisms regulating glioma invasion. Cancer Lett. 2015;362(1):1\u20137.","journal-title":"Cancer Lett"},{"issue":"6","key":"801_CR89","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3390\/cancers15061879","volume":"15","author":"S Marino","year":"2023","unstructured":"Marino S, Menna G, Di Bonaventura R, Lisi L, Mattogno P, Fig\u00e0 F, et al. The extracellular matrix in glioblastomas: a glance at its structural modifications in shaping the tumoral microenvironment\u2014a systematic review. Cancers. 2023;15(6):1879.","journal-title":"Cancers"},{"issue":"21","key":"801_CR90","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1111\/febs.15028","volume":"286","author":"J Zhang","year":"2019","unstructured":"Zhang J, Shi Z, Xu X, Yu Z, Mi J. The influence of microenvironment on tumor immunotherapy. FEBS J. 2019;286(21):4160\u201375.","journal-title":"FEBS J"},{"key":"801_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00375-7","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi J, Kevadiya BD, Muhammad IK, Herskovitz J, Olson KE, Mosley RL, et al. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener. 2020;15:1\u201326.","journal-title":"Mol Neurodegener"},{"issue":"14","key":"801_CR92","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1167\/iovs.19-27493","volume":"60","author":"N Xu","year":"2019","unstructured":"Xu N, Bo Q, Shao R, Liang J, Zhai Y, Yang S, et al. Chitinase-3-Like-1 promotes M2 macrophage differentiation and induces choroidal neovascularization in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2019;60(14):4596\u2013605.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"801_CR93","doi-asserted-by":"publisher","first-page":"16149","DOI":"10.3390\/ijms242216149","volume":"24","author":"H Zhao","year":"2023","unstructured":"Zhao H, Huang M, Jiang L. Potential roles and future perspectives of Chitinase 3-like 1 in macrophage polarization and the development of diseases. Int J Mol Sci. 2023;24(22):16149.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"801_CR94","doi-asserted-by":"publisher","first-page":"15612","DOI":"10.3390\/ijms232415612","volume":"23","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Graeber MB. Microglia and brain macrophages as drivers of glioma progression. Int J Mol Sci. 2022;23(24):15612.","journal-title":"Int J Mol Sci"},{"key":"801_CR95","doi-asserted-by":"publisher","first-page":"108031","DOI":"10.1016\/j.pharmthera.2021.108031","volume":"234","author":"E Conte","year":"2022","unstructured":"Conte E. Targeting monocytes\/macrophages in fibrosis and cancer diseases: therapeutic approaches. Pharmacol Ther. 2022;234:108031.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"801_CR96","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/cancers11101437","volume":"11","author":"J Wurm","year":"2019","unstructured":"Wurm J, Behringer SP, Ravi VM, Joseph K, Neidert N, Maier JP, et al. Astrogliosis releases pro-oncogenic chitinase 3-like 1 causing MAPK signaling in glioblastoma. Cancers. 2019;11(10):1437.","journal-title":"Cancers"},{"issue":"17","key":"801_CR97","doi-asserted-by":"publisher","first-page":"15332","DOI":"10.1074\/jbc.M110.212514","volume":"286","author":"RA Francescone","year":"2011","unstructured":"Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, et al. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011;286(17):15332\u201343.","journal-title":"J Biol Chem"},{"issue":"4","key":"801_CR98","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.celrep.2013.07.032","volume":"4","author":"CH He","year":"2013","unstructured":"He CH, Lee CG, Cruz CSD, Lee C-M, Zhou Y, Ahangari F, et al. Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor \u03b12. Cell Rep. 2013;4(4):830\u201341.","journal-title":"Cell Rep"},{"issue":"4","key":"801_CR99","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/cancers11040544","volume":"11","author":"E Deluche","year":"2019","unstructured":"Deluche E, Bessette B, Durand S, Caire F, Rigau V, Robert S, et al. CHI3L1, NTRK2, 1p\/19q and IDH status predicts prognosis in glioma. Cancers. 2019;11(4):544.","journal-title":"Cancers"},{"issue":"9","key":"801_CR100","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1158\/1078-0432.CCR-04-1765","volume":"11","author":"CE Pelloski","year":"2005","unstructured":"Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, et al. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res. 2005;11(9):3326\u201334.","journal-title":"Clin Cancer Res"},{"key":"801_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1516-2","volume":"16","author":"RL Jayaraj","year":"2019","unstructured":"Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16:1\u201324.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"801_CR102","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","volume":"17","author":"VL Feigin","year":"2022","unstructured":"Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(1):18\u201329.","journal-title":"Int J Stroke"},{"issue":"8","key":"801_CR103","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153\u2013639.","journal-title":"Circulation"},{"issue":"2","key":"801_CR104","first-page":"268","volume":"26","author":"AA Rabinstein","year":"2020","unstructured":"Rabinstein AA. Update on treatment of acute ischemic stroke. Continuum (Minneap Minn). 2020;26(2):268\u201386.","journal-title":"Continuum (Minneap Minn)"},{"issue":"12","key":"801_CR105","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.amjmed.2021.07.027","volume":"134","author":"SK Feske","year":"2021","unstructured":"Feske SK. Ischemic stroke. Am J Med. 2021;134(12):1457\u201364.","journal-title":"Am J Med"},{"issue":"9624","key":"801_CR106","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","volume":"371","author":"G Donnan","year":"2008","unstructured":"Donnan G, Fisher M, Macleod M, Davis S. Stroke. Lancet. 2008;371(9624):1612\u201323.","journal-title":"Lancet"},{"issue":"11","key":"801_CR107","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jama.2020.26867","volume":"325","author":"SJ Mendelson","year":"2021","unstructured":"Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. JAMA. 2021;325(11):1088\u201398.","journal-title":"JAMA"},{"issue":"5","key":"801_CR108","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","volume":"40","author":"M Gelderblom","year":"2009","unstructured":"Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe C-U, Siler DA, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40(5):1849\u201357.","journal-title":"Stroke"},{"issue":"3","key":"801_CR109","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/jcbfm.2013.217","volume":"34","author":"HX Chu","year":"2014","unstructured":"Chu HX, Kim HA, Lee S, Moore JP, Chan CT, Vinh A, et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab. 2014;34(3):450\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"801_CR110","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1139\/Y05-143","volume":"84","author":"AY Lai","year":"2006","unstructured":"Lai AY, Todd KG. Microglia in cerebral ischemia: molecular actions and interactions. Can J Physiol Pharmacol. 2006;84(1):49\u201359.","journal-title":"Can J Physiol Pharmacol"},{"issue":"12","key":"801_CR111","doi-asserted-by":"publisher","first-page":"e51722","DOI":"10.1371\/journal.pone.0051722","volume":"7","author":"HY Park","year":"2012","unstructured":"Park HY, Jun C-D, Jeon S-J, Choi S-S, Kim H-R, Choi D-B, et al. Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients. PLoS ONE. 2012;7(12):e51722.","journal-title":"PLoS ONE"},{"key":"801_CR112","doi-asserted-by":"publisher","first-page":"113082","DOI":"10.1016\/j.expneurol.2019.113082","volume":"323","author":"JH Im","year":"2020","unstructured":"Im JH, Yeo IJ, Park PH, Choi DY, Han S-B, Yun J, et al. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of Neuroinflammation by STAT6-dependent M2 microglial inactivation in Chitinase-3-like 1 knockout mice. Exp Neurol. 2020;323:113082.","journal-title":"Exp Neurol"},{"issue":"5","key":"801_CR113","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.bbi.2009.09.010","volume":"24","author":"A Denes","year":"2010","unstructured":"Denes A, Thornton P, Rothwell N, Allan S. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun. 2010;24(5):708\u201323.","journal-title":"Brain Behav Immun"},{"issue":"15","key":"801_CR114","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1523\/JNEUROSCI.21-15-05528.2001","volume":"21","author":"H Boutin","year":"2001","unstructured":"Boutin H, LeFeuvre R, Horai R, Asano M, Iwakura Y, Rothwell N. Role of IL-1\u03b1 and IL-1\u03b2 in ischemic brain damage. J Neurosci. 2001;21(15):5528\u201334.","journal-title":"J Neurosci"},{"issue":"5","key":"801_CR115","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1042\/BST0351119","volume":"35","author":"G Brown","year":"2007","unstructured":"Brown G. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans. 2007;35(5):1119\u201321.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"801_CR116","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/revneuro-2015-0017","volume":"27","author":"R Gupta","year":"2016","unstructured":"Gupta R, Sen N. Traumatic brain injury: a risk factor for neurodegenerative diseases. Rev Neurosci. 2016;27(1):93\u2013100.","journal-title":"Rev Neurosci"},{"issue":"2","key":"801_CR117","first-page":"337","volume":"32","author":"NB Chauhan","year":"2014","unstructured":"Chauhan NB. Chronic neurodegenerative consequences of traumatic brain injury. Restor Neurol Neurosci. 2014;32(2):337\u201365.","journal-title":"Restor Neurol Neurosci"},{"issue":"5","key":"801_CR118","first-page":"341","volume":"22","author":"AA Hyder","year":"2007","unstructured":"Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. 2007;22(5):341\u201353.","journal-title":"NeuroRehabilitation"},{"issue":"8","key":"801_CR119","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","volume":"7","author":"AI Maas","year":"2008","unstructured":"Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728\u201341.","journal-title":"Lancet Neurol"},{"issue":"2","key":"801_CR120","first-page":"213","volume":"104","author":"A Capizzi","year":"2020","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin. 2020;104(2):213\u201338.","journal-title":"Med Clin"},{"issue":"10","key":"801_CR121","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1089\/neu.2011.2034","volume":"28","author":"TM Andriessen","year":"2011","unstructured":"Andriessen TM, Horn J, Franschman G, van der Naalt J, Haitsma I, Jacobs B, et al. Epidemiology, severity classification, and outcome of moderate and severe traumatic brain injury: a prospective multicenter study. J Neurotrauma. 2011;28(10):2019\u201331.","journal-title":"J Neurotrauma"},{"issue":"1","key":"801_CR122","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/jcm10010148","volume":"10","author":"O Tenovuo","year":"2021","unstructured":"Tenovuo O, Diaz-Arrastia R, Goldstein LE, Sharp DJ, Van Der Naalt J, Zasler ND. Assessing the severity of traumatic brain injury\u2014time for a change? J Clin Med. 2021;10(1):148.","journal-title":"J Clin Med"},{"issue":"2","key":"801_CR123","first-page":"177","volume":"323","author":"ND Silverberg","year":"2020","unstructured":"Silverberg ND, Duhaime A-C, Iaccarino MA. Mild traumatic brain injury in 2019\u20132020. JAMA. 2020;323(2):177\u20138.","journal-title":"JAMA"},{"issue":"3","key":"801_CR124","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","volume":"72","author":"KN Corps","year":"2015","unstructured":"Corps KN, Roth TL, McGavern DB. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015;72(3):355\u201362.","journal-title":"JAMA Neurol"},{"issue":"6","key":"801_CR125","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41423-019-0213-5","volume":"16","author":"K Shi","year":"2019","unstructured":"Shi K, Zhang J, Dong J-F, Shi F-D. Dissemination of brain inflammation in traumatic brain injury. Cell Mol Immunol. 2019;16(6):523\u201330.","journal-title":"Cell Mol Immunol"},{"key":"801_CR126","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10787-012-0164-2","volume":"21","author":"J Finnie","year":"2013","unstructured":"Finnie J. Neuroinflammation: beneficial and detrimental effects after traumatic brain injury. Inflammopharmacology. 2013;21:309\u201320.","journal-title":"Inflammopharmacology"},{"issue":"3","key":"801_CR127","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/bc.bc_18_17","volume":"3","author":"SJ Schimmel","year":"2017","unstructured":"Schimmel SJ, Acosta S, Lozano D. Neuroinflammation in traumatic brain injury: a chronic response to an acute injury. Brain Circ. 2017;3(3):135\u201342.","journal-title":"Brain Circ"},{"issue":"3","key":"801_CR128","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/glia.20610","volume":"56","author":"AY Lai","year":"2008","unstructured":"Lai AY, Todd KG. Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia. 2008;56(3):259\u201370.","journal-title":"Glia"},{"issue":"4","key":"801_CR129","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.bbrc.2012.04.085","volume":"421","author":"MN Kim","year":"2012","unstructured":"Kim MN, Lee KE, Hong JY, Heo WI, Kim KW, Kim KE, et al. Involvement of the MAPK and PI3K pathways in chitinase 3-like 1-regulated hyperoxia-induced airway epithelial cell death. Biochem Biophys Res Commun. 2012;421(4):790\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"801_CR130","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12964-023-01423-7","volume":"22","author":"W Xu","year":"2024","unstructured":"Xu W, Chao R, Xie X, Mao Y, Chen X, Chen X, et al. IL13R\u03b12 as a crucial receptor for Chi3l1 in osteoclast differentiation and bone resorption through the MAPK\/AKT pathway. Cell Commun Signal. 2024;22(1):81.","journal-title":"Cell Commun Signal"},{"key":"801_CR131","doi-asserted-by":"publisher","first-page":"666361","DOI":"10.3389\/fimmu.2021.666361","volume":"12","author":"L Li","year":"2021","unstructured":"Li L, Wei K, Ding Y, Ahati P, Xu H, Fang H, et al. M2a macrophage-secreted CHI3L1 promotes extracellular matrix metabolic imbalances via activation of IL-13R\u03b12\/MAPK pathway in rat intervertebral disc degeneration. Front Immunol. 2021;12:666361.","journal-title":"Front Immunol"},{"issue":"11","key":"801_CR132","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2174\/1570159X19666210215123914","volume":"19","author":"N Khatri","year":"2021","unstructured":"Khatri N, Sumadhura B, Kumar S, Kaundal RK, Sharma S, Datusalia AK. The complexity of secondary cascade consequent to traumatic brain injury: pathobiology and potential treatments. Curr Neuropharmacol. 2021;19(11):1984.","journal-title":"Curr Neuropharmacol"},{"key":"801_CR133","first-page":"97","volume":"11","author":"D Lozano","year":"2015","unstructured":"Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, et al. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat. 2015;11:97\u2013106.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"801_CR134","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM. Alzheimer\u2019s disease. Eur J Neurol. 2018;25(1):59\u201370.","journal-title":"Eur J Neurol"},{"issue":"1","key":"801_CR135","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-024-00719-7","volume":"19","author":"LE de Vries","year":"2024","unstructured":"de Vries LE, Huitinga I, Kessels HW, Swaab DF, Verhaagen J. The concept of resilience to Alzheimer\u2019s disease: current definitions and cellular and molecular mechanisms. Mol Neurodegener. 2024;19(1):33.","journal-title":"Mol Neurodegener"},{"key":"801_CR136","unstructured":"Andersson C-H. The role of microglia in Alzheimer's disease-Investigating mechansims regulating amyloid-\u03b2 clearance. 2016."},{"issue":"2","key":"801_CR137","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/biom13020313","volume":"13","author":"W Cai","year":"2023","unstructured":"Cai W, Wu T, Chen N. The Amyloid-beta clearance: from molecular targets to glial and neural cells. Biomolecules. 2023;13(2):313.","journal-title":"Biomolecules"},{"issue":"1","key":"801_CR138","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000506282","volume":"49","author":"IO Woollacott","year":"2020","unstructured":"Woollacott IO, Nicholas JM, Heller C, Foiani MS, Moore KM, Russell LL, et al. Cerebrospinal fluid YKL-40 and chitotriosidase levels in frontotemporal dementia vary by clinical, genetic and pathological subtype. Dement Geriatr Cogn Disord. 2020;49(1):56\u201376.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"801_CR139","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","volume":"68","author":"R Craig-Schapiro","year":"2010","unstructured":"Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol Psychiat. 2010;68(10):903\u201312.","journal-title":"Biol Psychiat"},{"issue":"11","key":"801_CR140","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1038\/s41380-022-01716-2","volume":"27","author":"JP Ferrari-Souza","year":"2022","unstructured":"Ferrari-Souza JP, Ferreira PC, Bellaver B, Tissot C, Wang Y-T, Leffa DT, et al. Astrocyte biomarker signatures of amyloid-\u03b2 and tau pathologies in Alzheimer\u2019s disease. Mol Psychiatry. 2022;27(11):4781\u20139.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"801_CR141","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-023-00695-4","volume":"19","author":"G Son","year":"2024","unstructured":"Son G, Neylan TC, Grinberg LT. Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models. Mol Neurodegener. 2024;19(1):4.","journal-title":"Mol Neurodegener"},{"issue":"7","key":"801_CR142","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/14789450.2019.1628643","volume":"16","author":"F Baldacci","year":"2019","unstructured":"Baldacci F, Lista S, Palermo G, Giorgi FS, Vergallo A, Hampel H. The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development. Expert Rev Proteomics. 2019;16(7):593\u2013600.","journal-title":"Expert Rev Proteomics"},{"key":"801_CR143","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neurobiolaging.2015.10.022","volume":"38","author":"JD Gispert","year":"2016","unstructured":"Gispert JD, Mont\u00e9 GC, Falcon C, Tucholka A, Rojas S, S\u00e1nchez-Valle R, et al. CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD. Neurobiol Aging. 2016;38:47\u201355.","journal-title":"Neurobiol Aging"},{"issue":"574","key":"801_CR144","doi-asserted-by":"publisher","first-page":"eaax3519","DOI":"10.1126\/scitranslmed.aax3519","volume":"12","author":"BV Lananna","year":"2020","unstructured":"Lananna BV, McKee CA, King MW, Del-Aguila JL, Dimitry JM, Farias FH, et al. Chi3l1\/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer\u2019s disease pathogenesis. Sci Transl Med. 2020;12(574):eaax3519.","journal-title":"Sci Transl Med"},{"issue":"9423","key":"801_CR145","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR. Parkinson\u2019s disease. Lancet. 2004;363(9423):1783\u201393.","journal-title":"Lancet"},{"key":"801_CR146","doi-asserted-by":"crossref","unstructured":"Kouli A, Torsney KM, Kuan W-L. Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Parkinson\u2019s disease: pathogenesis and clinical aspects. Brisbane: Codon Publications; 2018. p. 3\u201326.","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"801_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL. Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener. 2017;6:1\u201335.","journal-title":"Transl Neurodegener"},{"key":"801_CR148","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbi.2018.03.020","volume":"70","author":"P Mackie","year":"2018","unstructured":"Mackie P, Lebowitz J, Saadatpour L, Nickoloff E, Gaskill P, Khoshbouei H. The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson\u2019s Disease. Brain Behav Immun. 2018;70:21\u201335.","journal-title":"Brain Behav Immun"},{"key":"801_CR149","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.mcn.2017.10.001","volume":"85","author":"C Sanfilippo","year":"2017","unstructured":"Sanfilippo C, Longo A, Lazzara F, Cambria D, Distefano G, Palumbo M, et al. CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients. Mol Cell Neurosci. 2017;85:162\u20139.","journal-title":"Mol Cell Neurosci"},{"key":"801_CR150","doi-asserted-by":"crossref","unstructured":"Verde F, Ticozzi N. Amyotrophic lateral sclerosis: neurochemical biomarkers. In: Acquired neuromuscular disorders: pathogenesis, diagnosis and treatment. Cham: Springer; 2022. p. 295-310.","DOI":"10.1007\/978-3-031-06731-0_16"},{"issue":"11","key":"801_CR151","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/jnnp-2019-320442","volume":"90","author":"AG Thompson","year":"2019","unstructured":"Thompson AG, Gray E, Bampton A, Raciborska D, Talbot K, Turner MR. CSF chitinase proteins in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(11):1215\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"801_CR152","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.18632\/aging.101551","volume":"10","author":"P Andr\u00e9s-Benito","year":"2018","unstructured":"Andr\u00e9s-Benito P, Dom\u00ednguez R, Colomina MJ, Llorens F, Povedano M, Ferrer I. YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression. Aging (Albany NY). 2018;10(9):2367.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"801_CR153","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/jnnp-2021-327503","volume":"93","author":"M Dreger","year":"2022","unstructured":"Dreger M, Steinbach R, Otto M, Turner MR, Grosskreutz J. Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2022;93(4):422\u201335.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"801_CR154","doi-asserted-by":"publisher","first-page":"1059994","DOI":"10.3389\/fimmu.2022.1059994","volume":"13","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Wang Z, Wei X, Yu X-F. Inflammatory checkpoints in amyotrophic lateral sclerosis: from biomarkers to therapeutic targets. Front Immunol. 2022;13:1059994.","journal-title":"Front Immunol"},{"key":"801_CR155","doi-asserted-by":"crossref","unstructured":"Arkelius K, Wendt TS, Andersson H, Arnou A, Gottschalk M, Gonzales RJ, et al. LOX-1 and MMP-9 inhibition attenuates the detrimental effects of delayed rt-PA therapy and improves outcomes after acute ischemic stroke. Circ Res. 2024;134(8):954-69.","DOI":"10.1161\/CIRCRESAHA.123.323371"},{"key":"801_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0562-4","volume":"12","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh S, Steinacker P, Polischi B, Mammana A, Bartoletti-Stella A, Oeckl P, et al. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia. Alzheimer\u2019s Res Ther. 2020;12:1\u201315.","journal-title":"Alzheimer's Res Ther"},{"key":"801_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0742-2","volume":"7","author":"BR Groveman","year":"2019","unstructured":"Groveman BR, Foliaki ST, Orru CD, Zanusso G, Carroll JA, Race B, et al. Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun. 2019;7:1\u201312.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"801_CR158","doi-asserted-by":"publisher","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann H. Multiple sclerosis pathology. Cold Spring Harb Perspect Med. 2018;8(3):a028936.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"801_CR159","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bbi.2018.01.010","volume":"69","author":"BA Silva","year":"2018","unstructured":"Silva BA, Leal MC, Far\u00edas MI, Avalos JC, Besada CH, Pitossi FJ, et al. A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: influence of innate immunity. Brain Behav Immun. 2018;69:515\u201331.","journal-title":"Brain Behav Immun"},{"issue":"24","key":"801_CR160","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1212\/WNL.0000000000009636","volume":"94","author":"FD Lublin","year":"2020","unstructured":"Lublin FD, Coetzee T, Cohen JA, Marrie RA, Thompson AJ, MS IACoCTi. The 2013 clinical course descriptors for multiple sclerosis: a clarification. Neurology. 2020;94(24):1088\u201392.","journal-title":"Neurology"},{"issue":"4","key":"801_CR161","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/brain\/awq035","volume":"133","author":"M Comabella","year":"2010","unstructured":"Comabella M, Fern\u00e1ndez M, Martin R, Rivera-Vallv\u00e9 S, Borr\u00e1s E, Chiva C, et al. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain. 2010;133(4):1082\u201393.","journal-title":"Brain"},{"issue":"11","key":"801_CR162","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1177\/1352458518794308","volume":"25","author":"F Sellebjerg","year":"2019","unstructured":"Sellebjerg F, Royen L, Soelberg S\u00f8rensen P, Oturai AB, Jensen PEH. Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis. Mult Scler J. 2019;25(11):1444\u201351.","journal-title":"Mult Scler J"},{"issue":"7","key":"801_CR163","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bbi.2012.07.007","volume":"26","author":"V Murta","year":"2012","unstructured":"Murta V, Pitossi FJ, Ferrari CC. CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved. Brain Behav Immun. 2012;26(7):1102\u201315.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"801_CR164","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/ene.13687","volume":"25","author":"E Quintana","year":"2018","unstructured":"Quintana E, Coll C, Salavedra-Pont J, Mu\u00f1oz-San Mart\u00edn M, Robles-Cede\u00f1o R, Tom\u00e0s-Roig J, et al. Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain. Eur J Neurol. 2018;25(9):1189\u201391.","journal-title":"Eur J Neurol"},{"issue":"4","key":"801_CR165","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/brain\/awy021","volume":"141","author":"C Matute-Blanch","year":"2018","unstructured":"Matute-Blanch C, Villar LM, \u00c1lvarez-Cerme\u00f1o JC, Rejdak K, Evdoshenko E, Makshakov G, et al. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome. Brain. 2018;141(4):1085\u201393.","journal-title":"Brain"},{"issue":"5","key":"801_CR166","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/1352458518767043","volume":"25","author":"E Thouvenot","year":"2019","unstructured":"Thouvenot E, Hinsinger G, Demattei C, Uygunoglu U, Castelnovo G, Pittion-Vouyovitch S, et al. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome. Mult Scler J. 2019;25(5):669\u201377.","journal-title":"Mult Scler J"},{"key":"801_CR167","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jneuroim.2016.01.013","volume":"292","author":"J Burman","year":"2016","unstructured":"Burman J, Raininko R, Blennow K, Zetterberg H, Axelsson M, Malmestr\u00f6m C. YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis. J Neuroimmunol. 2016;292:52\u20137.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"801_CR168","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1177\/1352458514561906","volume":"21","author":"G Hinsinger","year":"2015","unstructured":"Hinsinger G, Gal\u00e9otti N, Nabholz N, Urbach S, Rigau V, Demattei C, et al. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Mult Scler J. 2015;21(10):1251\u201361.","journal-title":"Mult Scler J"},{"key":"801_CR169","doi-asserted-by":"publisher","first-page":"483650","DOI":"10.3389\/fneur.2020.00608","volume":"11","author":"A Huss","year":"2020","unstructured":"Huss A, Otto M, Senel M, Ludolph AC, Abdelhak A, Tumani H. A score based on NfL and glial markers may differentiate between relapsing\u2013remitting and progressive MS course. Front Neurol. 2020;11:483650.","journal-title":"Front Neurol"},{"key":"801_CR170","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fneur.2019.01008","volume":"10","author":"S Gil-Perotin","year":"2019","unstructured":"Gil-Perotin S, Castillo-Villalba J, Cubas-Nu\u00f1ez L, Gasque R, Hervas D, Gomez-Mateu J, et al. Combined cerebrospinal fluid neurofilament light chain protein and chitinase-3 like-1 levels in defining disease course and prognosis in multiple sclerosis. Front Neurol. 2019;10:1008.","journal-title":"Front Neurol"},{"issue":"1","key":"801_CR171","doi-asserted-by":"publisher","first-page":"e906","DOI":"10.1212\/NXI.0000000000000906","volume":"8","author":"R Schneider","year":"2020","unstructured":"Schneider R, Bellenberg B, Gisevius B, Hirschberg S, Sankowski R, Prinz M, et al. Chitinase 3\u2013like 1 and neurofilament light chain in CSF and CNS atrophy in MS. Neurol Neuroimmunol Neuroinflamm. 2020;8(1):e906.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"801_CR172","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/1352458510392619","volume":"17","author":"J Correale","year":"2011","unstructured":"Correale J, Fiol M. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. Mult Scler J. 2011;17(5):521\u201331.","journal-title":"Mult Scler J"},{"key":"801_CR173","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-444-63849-6.00007-4","volume":"152","author":"RC Smail","year":"2018","unstructured":"Smail RC, Brew BJ. HIV-associated neurocognitive disorder. Handb Clin Neurol. 2018;152:75\u201397.","journal-title":"Handb Clin Neurol"},{"key":"801_CR174","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbi.2020.11.004","volume":"91","author":"B Lahooti","year":"2021","unstructured":"Lahooti B, Chhibber T, Bagchi S, Varahachalam SP, Jayant RD. Therapeutic role of inflammasome inhibitors in neurodegenerative disorders. Brain Behav Immun. 2021;91:771\u201383.","journal-title":"Brain Behav Immun"},{"key":"801_CR175","doi-asserted-by":"publisher","first-page":"793835","DOI":"10.3389\/fncel.2022.793835","volume":"16","author":"HJ Ham","year":"2022","unstructured":"Ham HJ, Lee YS, Lee HP, Ham YW, Yun J, Han SB, et al. G721\u20130282 Exerts Anxiolytic-Like Effects on Chronic Unpredictable Mild Stress in Mice Through Inhibition of Chitinase-3-Like 1-Mediated Neuroinflammation. Front Cell Neurosci. 2022;16:793835.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"801_CR176","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1878-0261.13152","volume":"16","author":"JE Yu","year":"2022","unstructured":"Yu JE, Yeo IJ, Son DJ, Yun J, Han SB, Hong JT. Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization. Mol Oncol. 2022;16(11):2214\u201334.","journal-title":"Mol Oncol"},{"key":"801_CR177","doi-asserted-by":"publisher","first-page":"466351","DOI":"10.3389\/fimmu.2019.02930","volume":"10","author":"J Kzhyshkowska","year":"2020","unstructured":"Kzhyshkowska J, Larionova I, Liu T. YKL-39 as a potential new target for anti-angiogenic therapy in cancer. Front Immunol. 2020;10:466351.","journal-title":"Front Immunol"},{"issue":"17","key":"801_CR178","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.3390\/ijms21176354","volume":"21","author":"K Kang","year":"2020","unstructured":"Kang K, Kim K, Lee S-R, Kim Y, Lee JE, Lee YS, et al. Selection and characterization of ykl-40-targeting monoclonal antibodies from human synthetic fab phage display libraries. Int J Mol Sci. 2020;21(17):6354.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"801_CR179","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/STROKEAHA.123.043764","volume":"55","author":"PT Ronaldson","year":"2024","unstructured":"Ronaldson PT, Williams EI, Betterton RD, Stanton JA, Nilles KL, Davis TP. CNS drug delivery in stroke: improving therapeutic translation from the bench to the bedside. Stroke. 2024;55(1):190\u2013202.","journal-title":"Stroke"},{"issue":"11","key":"801_CR180","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s11095-024-03790-3","volume":"41","author":"H Zeng","year":"2024","unstructured":"Zeng H, Lu H, Yang J, Hu P. An update on recent drug delivery systems targeting brain diseases via the transnasal pathway. Pharm Res. 2024;41(11):2121\u201341.","journal-title":"Pharm Res"},{"issue":"24","key":"801_CR181","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1021\/acschemneuro.1c00540","volume":"12","author":"M Amiri","year":"2021","unstructured":"Amiri M, Jafari S, Kurd M, Mohamadpour H, Khayati M, Ghobadinezhad F, et al. Engineered solid lipid nanoparticles and nanostructured lipid carriers as new generations of blood-brain barrier transmitters. ACS Chem Neurosci. 2021;12(24):4475\u201390.","journal-title":"ACS Chem Neurosci"},{"key":"801_CR182","doi-asserted-by":"crossref","unstructured":"Nayak U, Halagali P, Panchal K, Tippavajhala VK, Mudgal J, Radhakrishnan R, et al. Nanoparticles in CNS therapeutics: pioneering drug delivery advancements. Curr Pharm Des. 2024;31(6):443\u201360.","DOI":"10.2174\/0113816128328722240828184410"},{"issue":"16","key":"801_CR183","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1016\/j.bmc.2018.08.006","volume":"26","author":"Y Peng","year":"2018","unstructured":"Peng Y, Zhao Y, Chen Y, Yang Z, Zhang L, Xiao W, et al. Dual-targeting for brain-specific liposomes drug delivery system: synthesis and preliminary evaluation. Bioorg Med Chem. 2018;26(16):4677\u201386.","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"801_CR184","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","volume":"88","author":"PM Friden","year":"1991","unstructured":"Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk RM. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A. 1991;88(11):4771\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"801_CR185","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41571-023-00756-z","volume":"20","author":"MJ Mair","year":"2023","unstructured":"Mair MJ, Bartsch R, Le Rhun E, Berghoff AS, Brastianos PK, Cortes J, et al. Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours. Nat Rev Clin Oncol. 2023;20(6):372\u201389.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"801_CR186","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/ph17030307","volume":"17","author":"M-C Chang","year":"2024","unstructured":"Chang M-C, Chen C-T, Chiang P-F, Chiang Y-C. The role of Chitinase-3-like Protein-1 (YKL40) in the therapy of cancer and other chronic-inflammation-related diseases. Pharmaceuticals. 2024;17(3):307.","journal-title":"Pharmaceuticals"},{"key":"801_CR187","doi-asserted-by":"publisher","first-page":"100001","DOI":"10.1016\/j.allmed.2024.100001","volume":"1","author":"J Zeng","year":"2024","unstructured":"Zeng J, Tao M, Sun H, Xu G. The emerging role of CHI3L1 as a diagnostic marker and therapeutic target in allergic diseases and respiratory comorbidities. Allergy Med. 2024;1:100001.","journal-title":"Allergy Med"},{"issue":"1","key":"801_CR188","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12935-024-03425-y","volume":"24","author":"Y Fan","year":"2024","unstructured":"Fan Y, Meng Y, Hu X, Liu J, Qin X. Uncovering novel mechanisms of chitinase-3-like protein 1 in driving inflammation-associated cancers. Cancer Cell Int. 2024;24(1):268.","journal-title":"Cancer Cell Int"},{"issue":"24","key":"801_CR189","doi-asserted-by":"publisher","first-page":"13437","DOI":"10.3390\/ijms252413437","volume":"25","author":"D Liu","year":"2024","unstructured":"Liu D, Hu X, Ding X, Li M, Ding L. Inflammatory effects and regulatory mechanisms of Chitinase-3-like-1 in multiple human body systems: a comprehensive review. Int J Mol Sci. 2024;25(24):13437.","journal-title":"Int J Mol Sci"},{"key":"801_CR190","doi-asserted-by":"crossref","unstructured":"Choi J, Chen W, Liao H, Li X, Shendure J. A molecular proximity sensor based on an engineered, dual-component guide RNA. bioRxiv. 2024:2023.08. 14.553235.","DOI":"10.7554\/eLife.98110.2"},{"issue":"4","key":"801_CR191","doi-asserted-by":"publisher","first-page":"lnae031","DOI":"10.1093\/lifemedi\/lnae031","volume":"3","author":"J Chen","year":"2024","unstructured":"Chen J, Fang M, Li Y, Ding H, Zhang X, Jiang X, et al. Cell surface protein\u2013protein interaction profiling for biological network analysis and novel target discovery. Life Med. 2024;3(4):lnae031.","journal-title":"Life Med"},{"issue":"1","key":"801_CR192","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier. Nat Rev Neurosci. 2006;7(1):41\u201353.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"801_CR193","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1172\/JCI41911","volume":"120","author":"EH Wilson","year":"2010","unstructured":"Wilson EH, Weninger W, Hunter CA. Trafficking of immune cells in the central nervous system. J Clin Investig. 2010;120(5):1368\u201379.","journal-title":"J Clin Investig"},{"key":"801_CR194","doi-asserted-by":"publisher","first-page":"113508","DOI":"10.1016\/j.expneurol.2020.113508","volume":"335","author":"E Kim","year":"2021","unstructured":"Kim E, Cho S. CNS and peripheral immunity in cerebral ischemia: partition and interaction. Exp Neurol. 2021;335:113508.","journal-title":"Exp Neurol"},{"issue":"6","key":"801_CR195","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1242\/jcs.033837","volume":"122","author":"MM Frigault","year":"2009","unstructured":"Frigault MM, Lacoste J, Swift JL, Brown CM. Live-cell microscopy\u2013tips and tools. J Cell Sci. 2009;122(6):753\u201367.","journal-title":"J Cell Sci"},{"issue":"1","key":"801_CR196","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1021\/acsnano.5b03970","volume":"10","author":"N Liv","year":"2016","unstructured":"Liv N, van Oosten Slingeland DS, Baudoin J-P, Kruit P, Piston DW, Hoogenboom JP. Electron microscopy of living cells during in situ fluorescence microscopy. ACS Nano. 2016;10(1):265\u201373.","journal-title":"ACS Nano"},{"key":"801_CR197","doi-asserted-by":"crossref","unstructured":"Libreros S, Garcia-Areas R, Keating P, Gazaniga N, Robinson P, Humbles A, et al. Allergen induced pulmonary inflammation enhances mammary tumor growth and metastasis: Role of CHI3L1. J Leukoc Biol. 2015;97(5):929\u201340.","DOI":"10.1189\/jlb.3A0214-114RR"},{"issue":"3","key":"801_CR198","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/14789450.2020.1745069","volume":"17","author":"J-H Kim","year":"2020","unstructured":"Kim J-H, Afridi R, Lee W-H, Suk K. Proteomic examination of the neuroglial secretome: lessons for the clinic. Expert Rev Proteomics. 2020;17(3):207\u201320.","journal-title":"Expert Rev Proteomics"},{"issue":"5","key":"801_CR199","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1002\/jcp.26045","volume":"233","author":"R Ito","year":"2018","unstructured":"Ito R, Takahashi T, Ito M. Humanized mouse models: application to human diseases. J Cell Physiol. 2018;233(5):3723\u20138.","journal-title":"J Cell Physiol"},{"issue":"10","key":"801_CR200","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2174\/138920011798062265","volume":"12","author":"H-W Shen","year":"2011","unstructured":"Shen H-W, Jiang X-L, J. Gonzalez F, Yu A-M. Humanized transgenic mouse models for drug metabolism and pharmacokinetic research. Curr Drug Metab. 2011;12(10):997\u20131006.","journal-title":"Curr Drug Metab"},{"issue":"1","key":"801_CR201","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/0471143030.cb0411s59","volume":"59","author":"RK Benninger","year":"2013","unstructured":"Benninger RK, Piston DW. Two-photon excitation microscopy for the study of living cells and tissues.\u00a0Curr Protoc Cell Biol. 2013;59(1):4\u201311.","journal-title":"Curr Protoc Cell Biol"},{"issue":"1","key":"801_CR202","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0165-0270(01)00438-1","volume":"111","author":"M Oheim","year":"2001","unstructured":"Oheim M, Beaurepaire E, Chaigneau E, Mertz J, Charpak S. Two-photon microscopy in brain tissue: parameters influencing the imaging depth. J Neurosci Methods. 2001;111(1):29\u201337.","journal-title":"J Neurosci Methods"},{"issue":"6","key":"801_CR203","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuron.2006.05.019","volume":"50","author":"K Svoboda","year":"2006","unstructured":"Svoboda K, Yasuda R. Principles of two-photon excitation microscopy and its applications to neuroscience. Neuron. 2006;50(6):823\u201339.","journal-title":"Neuron"},{"issue":"3","key":"801_CR204","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41592-023-01791-5","volume":"20","author":"HM Bennett","year":"2023","unstructured":"Bennett HM, Stephenson W, Rose CM, Darmanis S. Single-cell proteomics enabled by next-generation sequencing or mass spectrometry. Nat Methods. 2023;20(3):363\u201374.","journal-title":"Nat Methods"},{"issue":"8","key":"801_CR205","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.tibs.2021.01.013","volume":"46","author":"LF Vistain","year":"2021","unstructured":"Vistain LF, Tay S. Single-cell proteomics. Trends Biochem Sci. 2021;46(8):661\u201372.","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"801_CR206","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1517\/17460441.2015.1061991","volume":"10","author":"H Zheng","year":"2015","unstructured":"Zheng H, Handing KB, Zimmerman MD, Shabalin IG, Almo SC, Minor W. X-ray crystallography over the past decade for novel drug discovery\u2013where are we heading next? Expert Opin Drug Discov. 2015;10(9):975\u201389.","journal-title":"Expert Opin Drug Discov"},{"key":"801_CR207","doi-asserted-by":"crossref","unstructured":"Kong Y, Killer M, Sevvana M, Rapisarda C. Cryo-EM in drug discovery. In: Cryo-Electron microscopy in structural biology.\u00a0Boca Raton: CRC Press; 2024. p. 429\u201345.","DOI":"10.1201\/9781003326106-40"},{"issue":"1","key":"801_CR208","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40169-018-0211-8","volume":"7","author":"D Ghosh","year":"2018","unstructured":"Ghosh D, Nandi S, Bhattacharjee S. Combination therapy to checkmate Glioblastoma: clinical challenges and advances. Clin Transl Med. 2018;7(1):33.","journal-title":"Clin Transl Med"},{"issue":"6","key":"801_CR209","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jnc.15824","volume":"165","author":"F Li","year":"2023","unstructured":"Li F, Liu A, Zhao M, Luo L. Astrocytic Chitinase-3-like protein 1 in neurological diseases: potential roles and future perspectives. J Neurochem. 2023;165(6):772\u201390.","journal-title":"J Neurochem"},{"issue":"1","key":"801_CR210","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1146\/annurev.neuro.24.1.1071","volume":"24","author":"R Yuste","year":"2001","unstructured":"Yuste R, Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci. 2001;24(1):1071\u201389.","journal-title":"Annu Rev Neurosci"},{"issue":"9","key":"801_CR211","first-page":"2727","volume":"20","author":"Y Liu","year":"2025","unstructured":"Liu Y, Han X, Su Y, Zhou Y, Xu M, Xu J, et al. Recombinant chitinase-3-like protein 1 alleviates learning and memory impairments via M2 microglia polarization in postoperative cognitive dysfunction mice. Neural Regen Res. 2025;20(9):2727\u201336.","journal-title":"Neural Regen Res"},{"key":"801_CR212","unstructured":"Querol-Vilaseca M. Novel digital neuropathology methods applied to neurodegenerative diseases. 2020."},{"issue":"2","key":"801_CR213","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/archneur.62.2.196","volume":"62","author":"CA Mathis","year":"2005","unstructured":"Mathis CA, Klunk WE, Price JC, DeKosky ST. Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies. Arch Neurol. 2005;62(2):196\u2013200.","journal-title":"Arch Neurol"},{"issue":"19","key":"801_CR214","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.3390\/ijms231911612","volume":"23","author":"LE Linders","year":"2022","unstructured":"Linders LE, Supiot LF, Du W, D\u2019Angelo R, Adan RA, Riga D, et al. Studying synaptic connectivity and strength with optogenetics and patch-clamp electrophysiology. Int J Mol Sci. 2022;23(19):11612.","journal-title":"Int J Mol Sci"},{"key":"801_CR215","doi-asserted-by":"publisher","first-page":"110298","DOI":"10.1016\/j.jneumeth.2024.110298","volume":"412","author":"T Kashima","year":"2024","unstructured":"Kashima T, Sasaki T, Ikegaya Y. Optogenetic estimation of synaptic connections in brain slices. J Neurosci Methods. 2024;412:110298.","journal-title":"J Neurosci Methods"},{"issue":"9","key":"801_CR216","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3390\/polym15092196","volume":"15","author":"L Duan","year":"2023","unstructured":"Duan L, Li X, Ji R, Hao Z, Kong M, Wen X, et al. Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases. Polymers. 2023;15(9):2196.","journal-title":"Polymers"},{"key":"801_CR217","doi-asserted-by":"publisher","first-page":"114619","DOI":"10.1016\/j.addr.2022.114619","volume":"191","author":"H-J Liu","year":"2022","unstructured":"Liu H-J, Xu P. Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor. Adv Drug Deliv Rev. 2022;191:114619.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00801-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T13:06:50Z","timestamp":1737205610000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00801-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":217,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00801-8","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}